FDA Approved: ONUREG — Supplemental Application (Celgene Corporation)

View source ↗

Summary

The FDA approved a supplemental application for ONUREG (azacitidine) from Celgene Corporation, expanding its labeling to include maintenance therapy for adults …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Onureg (azacitidine)

Snippet

SUPPL AP for ONUREG (AZACITIDINE)